Repros Therapeutics (RPRX)

16.69 -0.32  -1.88%  May 17, 8:00PM
Add to Watchlists Create an Alert

Repros Therapeutics Cash from Operations TTM:

-13.50M for Dec. 31, 2012
View Full Chart

Repros Therapeutics Cash from Operations TTM Chart

    Repros Therapeutics Historical Cash from Operations TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -13.50M
    Sept. 30, 2012 -10.73M
    June 30, 2012 -10.27M
    March 31, 2012 -10.51M
    Dec. 31, 2011 -9.764M
    Sept. 30, 2011 -8.328M
    June 30, 2011 -6.48M
    March 31, 2011 -5.593M
    Dec. 31, 2010 -4.952M
    Sept. 30, 2010 -8.465M
    June 30, 2010 -9.467M
    March 31, 2010 -16.30M
    Dec. 31, 2009 -22.08M
    Sept. 30, 2009 -22.68M
    June 30, 2009 -24.98M
    March 31, 2009 -22.52M
    Dec. 31, 2008 -21.74M
    Sept. 30, 2008 -17.32M
    June 30, 2008 -17.80M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Cash From Operations (TTM)

    Definition: Cash from Operations

    Learn More

    Get data for

    RPRX Cash from Operations TTM Benchmarks

    Companies
    Cleveland BioLabs -20.65M
    Transcept Pharmaceuticals -15.20M
    Sarepta Therapeutics -29.69M

    RPRX Cash from Operations TTM Rankings

    Overall 39th percentile
    4567 of 7590
    Sector 31st percentile
    448 of 651 in Healthcare
    Industry 53rd percentile
    111 of 238 in Biotechnology

    RPRX Cash from Operations TTM Range, Past 5 Years

    Minimum -24.98M Jun 2009
    Maximum -4.952M Dec 2010
    Average -13.87M